Mesalaminedosage
mesalamine 500 MG Extended Release Oral Capsule
Dosage and administration
Evaluate renal function prior to initiation of mesalamine extended-release capsules and periodically while on therapy. Recommended Dosage The recommended dosage for the induction of remission and the symptomatic treatment of mildly to moderately active ulcerative colitis in adults is 1 g (4 mesalamine extended-release 250 mg capsules or 2 mesalamine extended-release 500 mg capsules) administered orally four times daily. Administration Instructions
Swallow mesalamine extended-release capsules whole; do not crush or chew.
Alternatively, the capsule(s) may be opened and the entire contents sprinkled onto applesauce or yogurt. Consume the entire mixture immediately.
Drink an adequate amount of fluids during treatment.
Evaluate renal function prior to initiation of mesalamine extended-release capsules and periodically while on therapy.
The recommended dosage is 1 g administered orally four times daily.
Swallow capsules whole; do not crush or chew.
Alternatively, the capsule(s) may be opened and the contents sprinkled onto applesauce or yogurt.
Drink an adequate amount of fluids.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective June 30, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance